ILSI-Biomed Israel

Almost-Breakthroughs of the Year: Genetic Engineering and Longevity Drug

The magazine Science picked two runner-ups for the Breakthrough of the Year award: genetic engineering and a novel longevity drug Do you read Science, the magazine? You really should. It's one of the best sources for breakthroughs in research. This month they have a special section, where they tried to pick the Breakthrough of the Year. They probably had to do quite a lot of thinking, but eventually they settles on the discovery of Ardi - the missing link between our ancient ape-like ance...

EnzySurge, Maker of DermaStream® Secures $2.5 Million in Private Capital

  Richmond, VA. USA / Rosh Ha’Ayin, Israel, December 22st, 2009 – EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $2.5 million. The round was led by Eli Gilboa, CPA, of Gilboa & Licht, who serves as the company’s active chairman at a company valuation of $18.5 million. To date, the company has raised a total US$10 million. Proceeds will be used to acce...

Photos from ILSI-BioMed 2009, and New Events

Looking for life science events in Israel? Take a look in our Events Section, where we post every major new event in the field of bio-medicine and bio-technology in Israel. The newest event - Seminar: Patient Recruitment: Key Success Factor in Clinical Trials, January 19, 2010 Also, pay attention to the upper-right corner of the website, where you can find a large number of photos and images taken in the ILSI-BioMed week of 2009. See if you can find yourself!

Seminar: Patient Recruitment: Key Success Factor in Clinical Trials, January 19, 2010

SAVE THE DATE January 19, 2010, 4:00-7:00 PM Beit Chel Ha’avir, 15 Jabotinski Street, Herzelia Patient Recruitment: Key Success Factor in Clinical Trials The seminar will focus on issues related to excellence in clinical trial management, highlighting patient recruitment as a key to success. We will use case studies presented by: Dr. Yael Kenan, TransPharma Medical COO and ex Teva’s Global Clinical Drug Development in the field of Parkinson disease Dr. Yael Margolin, Gamida Cel...

Study Redefines Placebo Effect as Part of Effective Treatment

A new study redefines placebo effect as part of effective treatment in psoriasis, by treating patients with one quarter of their usual dose. The placebo effect is one of the most confounding aspects of every medical drug. When I’m taking this paracetamol – is it the drug doing the work, or is my brain fooling me? Both, most probably. But how much of each? And can we design drugs that will make smart use of the placebo effect? Well, such drugs exist already, as homeopathic remedies whic...

The First Scientific Agreement between Japan and Israel

Researchers from the Technion and Japan will collaborate to develop a platform for the creation of blood vessels and cells from embryonic stem cells. Prime Minister Binyamin Netanyau said last week that the children of Israel should study Chinese as well as English. Personally, I would like to see more Israeli children doing the final exams, but I agree with his general approach. It's pretty obvious that the market is heading east: to India, China and Japan. And it's just as obvious that ...

ISRANALYTICA – The 13th Annual Meeting of the Israel Analytical Chemistry Society

The 13th Annual Meeting of the Israel Analytical Chemistry Society: Conference & Exhibition. January 19-20, 2010, David Intercontinental Hotel, Tel-Aviv, Israel.   F0r the Conference Website - Press HERE   עמיתים יקרים בשם הוועדה המארגנת אני שמח להזמינכם להשתתף בכינוס ה-13 של החברה הישראלית לכימיה אנליטית – ישראנליטיקה 2010. המפגשים השנתיים של החברה הישראלית לכימיה אנליטית הפכו למפגשים הגדולים והחשובים ביותר בתחום הכימיה בישראל בכינוסי ישראנליטיקה שנערכו בשנים האחרונות השתתפו כ-...

Annual Meeting of the Israel Chapter of PDA

Annual Meeting of the Israel Chapter of PDA, Sunday, 3 January 2010 If you can't read this correctly, press HERE  15:30-21:00h The Shefayim Conventions Center, (Transparent Garden) A professional and social a festive dinner Program: Duration Topic Speaker 15:30 - 16:00 Registration, Coffee and Vendors Exhibits 16:00 – 16:10 President's Welcome Dr. Raphy Bar BR Consulting 16:10– 16:20 Treasurer's Report Karin Baer Omrix Bio...

מהנדס פיתוח

מהנדס להובלת פרויקט פיתוח של מערכת רב תחומית ליישומים אסטטיים. משרה - מהנדס פיתוח הגדרה - מהנדס להובלת פרויקט פיתוח של מערכת רב תחומית ליישומים אסטטיים.   דרישות: הכרחי : מהנדס ביו- רפואה או אלקטרוניקה – חובה ניסיון בן שנתיים בפיתוח מכשור רפואי רב תחומי בתעשייה - חובה ניסיון עבודה במעבדת אלקטרוניקה - חובה ניסיון בהפעלת קבלני משנה/ ספקים רצוי: יכולת תכנון מכאנית  הכרות עם מערכות אולטרא סאונד הכרות עם תחום האסטטיקה התפקיד דורש יצירתיות חדשנות יכולת אינטגרציה, הפעלת קבלני משנה ו...

EnzySurge Receives FDA Approval for SilverStream™ Innovative Wound Management Solution

A novel therapeutic method, which can be used for the treatment of pressure ulcers, diabetic ulcers, post-surgical wounds and first and second degree burns, has received the FDA clearance Rosh Ha’Ayin, Israel, December 15, 2009 – EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market  its new SilverStream™ solution for prescri...